Join us for a dynamic day of education designed specifically for APPs and nurses, featuring expert-led sessions across hematologic and solid tumor malignancies, including:
Through interactive discussions, real-world case applications, and actionable clinical guidance, this day of education will leave you better equipped to bring back immediately applicable strategies to your clinical practice.
November
072026
8:30 AM - 9:30 AM Central Time (CT)
Virtual
November
072026
9:30 AM - 10:30 AM Central Time (CT)
Virtual
November
072026
11:00 AM - 12:00 PM Central Time (CT)
Virtual
November
072026
12:45 PM - 1:45 PM Central Time (CT)
Virtual
To claim credit, click the link below, complete the evaluation, and you'll be given access to your certificate.
Multiple Myeloma CP-CML HER2-Negative MBC CAR T-Cell Therapy




In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.
The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points in the following ILNA subject areas:
Total Points: 1.0*
*Note that the course content applies to multiple subject areas across multiple credentials. The numerical value indicated above is the maximum number of points that can be claimed in each subject area. The total amount of ILNA points claimed may not exceed the total amount of nursing continuing professional development (NCPD) or CME awarded from this course and may only apply to the credential you are renewing.
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC dba Decera Clinical Education and CLL Society. Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.
The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points in the following ILNA subject areas:
Total Points: 1.0*
*Note that the course content applies to multiple subject areas across multiple credentials. The numerical value indicated above is the maximum number of points that can be claimed in each subject area. The total amount of ILNA points claimed may not exceed the total amount of nursing continuing professional development (NCPD) or CME awarded from this course and may only apply to the credential you are renewing.
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.
The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points in the following ILNA subject areas:
Total Points: 1.0*
*Note that the course content applies to multiple subject areas across multiple credentials. The numerical value indicated above is the maximum number of points that can be claimed in each subject area. The total amount of ILNA points claimed may not exceed the total amount of nursing continuing professional development (NCPD) or CME awarded from this course and may only apply to the credential you are renewing.
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
From Target to Tolerability: Nurse-Led Strategies for Optimizing Bispecific Antibody Therapy in Multiple Myeloma
Provided by Clinical Care Options, LLC dba Decera Clinical Education.
Supported by an educational grant from Johnson & Johnson.
Advances in Personalized TKI Therapy for CP-CML: Nursing Considerations to Enhance Patient Education, Tolerability, and Adherence
Provided by Clinical Care Options, LLC dba Decera Clinical Education.
Supported by an educational grant from Novartis Pharmaceuticals Corporation.
Navigating HER2-Negative MBC: An Oncology Nurse Roadmap to Maximize Efficacy and Enhance Tolerability With Antibody–Drug Conjugates
Provided by Clinical Care Options, LLC dba Decera Clinical Education.
This activity is supported by an educational grant from Gilead Sciences, Inc.
CAR T-Cell Therapy in Community and Shared-Care Settings: Practical Strategies to Manage Delayed and Long-term Toxicities
Provided by Clinical Care Options, LLC dba Decera Clinical Education.
This activity is supported by educational grants from Bristol Myers Squibb and Johnson & Johnson.
You are leaving the site. The new destination site may have a different terms of use and privacy policy.
We've updated our ad policy. Please review our policy here. Click 'Agree' to accept. If you do not accept, you cannot proceed to the site.
By clicking "Agree," you are agreeing to our Privacy Policy, Terms & Conditions and Ad Policy.
Instagram does not support direct URL sharing. Copy the link below and paste it into your Instagram post, story, or DM.
Instagram does not support direct URL sharing. Copy the link below and paste it into your Instagram post, story, or DM.